5α-Reductase Type 1 Immunostaining is Enhanced in Some Prostate Cancers Compared With Benign Prostatic Hyperplasia Epithelium - Concepedia

Concepedia

Publication | Closed Access

5α-Reductase Type 1 Immunostaining is Enhanced in Some Prostate Cancers Compared With Benign Prostatic Hyperplasia Epithelium

80

Citations

22

References

2003

Year

Lynn N. Thomas, R.C. Douglas, John P. Vessey, Rekah Gupta, Dorrie K. Fontaine, Richard W. Norman, Ian M. Thompson, Dean A. Troyer, Roger S. Rittmaster, Catherine B. Lazier

The Journal of Urology

Abstract

The presence of increased 5alphaR1 in some prostatic malignancies suggests that it is worthwhile to investigate the use of a dual 5alphaR inhibitor to prevent or treat early stage prostate cancer.

References

	Year	Citations

Page 1